Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
12.31
-0.91 (-6.88%)
At close: Sep 17, 2025, 4:00 PM EDT
12.31
0.00 (0.00%)
After-hours: Sep 17, 2025, 4:00 PM EDT
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $231.30 million as of September 17, 2025. Its market cap has decreased by -38.12% in one year.
Market Cap
231.30M
Enterprise Value
-4.34M
1-Year Change
-38.12%
Ranking
Category
Stock Price
$12.31
Market Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $231.30M, a decrease of -94.40%. That is a compound annual growth rate of -49.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 253.97M | 35.83% |
| Dec 31, 2024 | 186.98M | -61.73% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
| Jun 17, 2021 | 4.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |